Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy (Q45740619)

15 December 2017

Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy (English)

1 reference

15 December 2017

Behrens GM

1

1 reference

15 December 2017

Meyer D

series ordinal

2

1 reference

15 December 2017

Stoll M

series ordinal

3

1 reference

15 December 2017

Schmidt RE

series ordinal

4

1 reference

15 December 2017

1 August 2000

1 reference

15 December 2017

1 reference

15 December 2017

202

1 reference

15 December 2017

2

1 reference

15 December 2017

186-193

1 reference

Viral dynamics in HIV-1 infection.

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Failure of T-cell homeostasis preceding AIDS in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Changes in thymic function with age and during the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Cytomegalovirus retinitis in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

Highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980065-0

7 January 2021

10.1016/S0171-2985(00)80065-0

Identifiers

DOI

0 references

1 reference